Applied Therapeutics, Inc. corporate insiders have only been selling lately: one insider unloaded about $4,730 of stock over 12 months, with no open-market purchases.
Selling on its own is common and often pre-planned (10b5-1 plans, taxes, diversification), so it matters more when it is unusually heavy or broad.
No open-market insider buying or selling in the last full quarter. Insiders bought in 0 of the last 7 full quarters.
| Filed | Insider | Role | Type | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|
| Dec 18, 2025 | Kanter Stacy J. | Director | Sell | 43,000 | $0.11 | $5K | SEC |
| Mar 6, 2025 | Perfetti Riccardo | Executive Officer | Sell | 10,366 | $0.44 | $5K | SEC |
| Mar 6, 2025 | Funtleyder Leslie D. | Officer | Sell | 14,502 | $0.44 | $6K | SEC |
| Mar 6, 2025 | Chinoporos Constantine | Officer | Sell | 447 | $0.44 | $197 | SEC |
| Feb 7, 2025 | Funtleyder Leslie D. | Officer | Sell | 22,950 | $0.61 | $14K | SEC |
| Feb 7, 2025 | Perfetti Riccardo | Executive Officer | Sell | 86,078 | $0.61 | $53K | SEC |
| Feb 7, 2025 | Chinoporos Constantine | Officer | Sell | 28,117 | $0.61 | $17K | SEC |
| Aug 23, 2024 | Funtleyder Leslie D. | CFO | Sell | 13,530 | $5.83 | $79K | SEC |
| Aug 23, 2024 | Perfetti Riccardo | Executive Officer | Sell | 22,681 | $5.83 | $132K | SEC |
| Aug 14, 2024 | Shendelman Shoshana | CEO | Sell | 119,591 | $5.93 | $709K | SEC |
| Aug 14, 2024 | Shendelman Shoshana | CEO | Sell | 300,000 | $5.98 | $1.8M | SEC |
| Aug 14, 2024 | Shendelman Shoshana | CEO | Sell | 357,423 | $6.18 | $2.2M | SEC |
| Jun 10, 2024 | Shendelman Shoshana | CEO | Sell | 61,795 | $4.32 | $267K | SEC |
| Jun 10, 2024 | Perfetti Riccardo | Executive Officer | Sell | 22,003 | $4.32 | $95K | SEC |
| Jun 10, 2024 | Funtleyder Leslie D. | CFO | Sell | 16,980 | $4.32 | $73K | SEC |
In the last 12 months Applied Therapeutics, Inc. insiders made open-market purchases worth about $0 and sales worth about $4,730. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
The most recent open-market insider trade in APLT was filed on 2025-12-18.
No congressional trades in APLT were reported in the past two years. The full list is free on CapitalSnitch.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1). Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).